Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine With or Without Erlotinib in Metastatic Pancreatic Cancer
NCT01608841Phase 2Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jul 2005
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in pancreatic cancer (PC), sponsored by Taipei Veterans General Hospital. Status: unknown.
02
Drugs
erlotinib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01608841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01608841.